English Summary
IMAGING IN ISCHEMIC STROKE:
STATE OF THE ART
N. Venketasubramanian*, Myrna
Justina**
*Senior Consultant of Neuro-
sonology, National Neuroscience
Institute (NNI), Singapore
**Medical Officer, Mitra Keluar-
ga Bekasi Hospital, Indonesia
Exciting advances in ana-
tomical imaging have greatly
improved our capacity to detect
pathologic process in nervous
system , localize these processes
in the nervous system precisely,
and predict the type of disease.
The rapid evolution of techni-
ques of anatomical imaging has
occurred in parallel with
developments in physiological
imaging.
Cermin Dunia Kedokt.2007;34(4):181-5
nv, mj
EFFECTS OF EPILEPSY ON
PATIENTS' DAILY LIFE
Rizaldy Pinzon
Dept. of Neurology, Dr. M.
Haulussy Regional Hospital,
Ambon, Indonesia
Epilepsy is one of the most
common neurological disorders
with complex problem. Epilepsy
places a significant burden on
communities, especially in
developing countries where it
may remain largely untreated.
This review showed that injury rate
and mortality rate were higher
among epilepsy sufferers than in
normal population.
In addition to physical and
mental disability, epilepsy often
results in serious psychosocial
consequences for the individual
and the family. The stigma
attached to epilepsy prevents
individuals with epilepsy from
normal daily life, including
education, marriage, work and
sports.
Cermin Dunia Kedokt.2007;34(4):192-5
rp
CHEMICAL COMPONENTS OF
PIPER METHYSTICUM
Andria Agusta, Yuliasri Jamal
Treub Laboratory, Botanical Re-
search and Development, Cen-
ter for Biological Research and
Development, Indonesian Insti-
tute of Science, Bogor, Indonesia
Wati (P. methysticum) has
been known as a narcotic plant.
Sixty-one components consisted
of alkanes, oxygenated hydro-
carbons, fatty acids, steroids and
alkaloids were detected from
stem extract using GCMS ana-
lysis. Ten major components were
identified as 4,11,11-trimethyl-8-
methylen bicyclo-7,2,0- unec-4-
ena; 1-(2-methoxy-benzoil)-2-
(methoxy-methyl) pirolidina; p-
undecyl anisol; dihydro-kawain;
dihydromethystisin;yangonin; 2,3-
dihydro-3,5-dihydro-xy-6-methyl-
4H-pyran-4-on, levulinic acid and
2 unknown components; the
other fifty-one are minor
components.
Cermin Dunia Kedokt.2007;34(4):211-6
aa, yj
PROCESS IN UMBILICAL CORD
BLOOD BANKING
Maria Teresa Wijaya, Ferry
Sandra
Stem Cell and Cancer Institute,
Kalbe Farma Pharmaceutical
Company, Jakarta, Indonesia
Since its first application in
allogeneic transplantation in
1988, umbilical cord blood has
been mentioned in literatures as
an alternative source of stem
cells to bone marrow. And given
all the advantages that it has to
offer, umbilical cord blood is
slowly gaining its position to
replace bone marrow as the
main source of stem cells for
therapy. As its significance in the
clinical setting increases, ideas
start to emerge to build UCB
banks to store the stem cells for
future use. The processes in UCB
banking can generally be
divided into three steps: isolation
of UCB, processing and
screening, and the long-term
storage. In each of these
processes, there are many
factors that could affect the
quality of the UCB obtained.
Since the quality of the
transplanted unit plays a very
crucial role in determining the
success of UCB transplantation, it
is imperative to maximize the
outcome of each of the steps in
UCB banking.
Cermin Dunia Kedokt.2007;34(4):217-20
mtw, fsa
Cermin Dunia Kedokteran No. 157, 2007
172